Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2593–2616 of 15,667 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Activities. Clear all

Conditions: Neoplasms, Melanoma
Interventions: Modakafusp Alfa, Pembrolizumab; Drug
Lead sponsor: Teva Branded Pharmaceutical Products R&D LLC; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 15
States / cities: Duarte, California • La Jolla, California • Los Angeles, California + 12 more

Conditions: Veterans' Disability Claims
Interventions: Benefits Counseling, VA Orientation; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Obesity, Pediatric
Interventions: Virtual Health Coach; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 9 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Activity, Motor, Sleep, Delirium
Interventions: Wireless Wearable Device; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hematopoietic and Lymphoid System Neoplasm, Lymphedema, Malignant Solid Neoplasm
Interventions: Bioelectric Impedance Analysis, Exercise, Photoplethysmography, Questionnaire Administration; Procedure · Other · Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Social Anxiety Disorder
Interventions: Seromycin, Virtual Reality Exposure Therapy, Placebo; Drug · Behavioral
Lead sponsor: Georgia State University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Advanced Solid Tumor
Interventions: YL-15293; Drug
Lead sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Whittier, California • New York, New York • Houston, Texas

Conditions: Cerebellar Disorders, Cerebellar Degeneration, Cerebellar Atrophy, Cerebellar Lesions
Interventions: High-intensity training in variable contexts, Conventional balance training; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Post-Traumatic Stress Disorder
Interventions: Cognitive behavioral therapy (CBT), Brief PTSD treatment; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 5
States / cities: Monmouth Junction, New Jersey • New Brunswick, New Jersey • Newark, New Jersey

Conditions: Epilepsy, Seizures, Cognitive Impairment, Mild, Memory Disorder, Memory Loss
Interventions: COBENFY KarXT (50/20 mg), Control; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Solid Tumor
Interventions: GS-1206; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Grand Rapids, Michigan • Dallas, Texas • San Antonio, Texas

Conditions: Whiplash Injuries
Interventions: Behavioral treatments, Physical therapy; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 20 Years to 65 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2007
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: SCI - Spinal Cord Injury
Interventions: Epidural Stimulation Programs; Device
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Type 2 Diabetes
Interventions: Routine Care + Glycemic Excursion Minimization (RC+GEM), Routine Care (RC); Behavioral · Other
Lead sponsor: Chiara Fabris, PhD; Other
Eligibility: 30 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado • Charlottesville, Virginia

Conditions: Heart Failure, Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III
Interventions: PP-MI Intervention, MI-alone Intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 20 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colitis, Ulcerative
Interventions: Golimumab; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 9
States / cities: Phoenix, Arizona • Los Angeles, California • San Francisco, California + 6 more

Conditions: Nicotine Dependence
Interventions: Behavioral Counseling, Self-help control; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Leukemia, Multiple Myeloma and Plasma Cell Neoplasm
Interventions: biologic sample preservation procedure, immunologic technique, laboratory biomarker analysis; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: Not listed
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chronic Disease
Interventions: Expanded Food and Nutrition Education Program (EFNEP); Behavioral
Lead sponsor: South Dakota State University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 4
States / cities: Fort Collins, Colorado • Gainesville, Florida • College Park, Maryland + 1 more

Conditions: Cognition, Aging
Interventions: Minds in Motion; Behavioral
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 60 Years to 74 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Healthy
Interventions: tDCS, Sham tDCS; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Intellectual Disability, Exercise, Obesity
Interventions: Resistance Training for Empowerment (RT-POWER), A traditional RT intervention; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 44 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Polysubstance Addiction, Opioid Medication Assisted Treatment, Treatment Adherence, Retention in Care, Substance-Related Disorders
Interventions: Peer-Delivered Behavioral Activation ("Peer Activate"); Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • College Park, Maryland + 1 more

Search by objective public record fields.

A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

Benefits Counseling to Preserve Function Among Disability Applicants

Redesigning Pediatric Primary Care Obesity Treatment: Virtual House Calls

Quantifying Activity Using Wireless Wearable Technology

Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study

D-Cycloserine and Virtual Reality Exposure Therapy

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

Variable Intense Training for Ataxia and Locomotion

Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental Illnesses

Cholinergic Enhancement of Theta

A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors

Preventing Chronic Whiplash Pain

Long-term Follow-up for Epidural Stimulation in SCI

Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

Promoting Well-being and Health in Heart Failure

Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress

A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis

Counseling to Reduce Children's SHS Exposure: A Trial With Maternal Smokers

Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer

Biomarker Cost-Benefit Analysis of EFNEP

Exercise, Executive Processes and the Aging Brain

Activating and Identifying Neural Responses to Social Rejection: a Combined tDCS and fMRI Study

Effects of Guided Exercise on Functional Performance and Independence in Adults With Intellectual Disability

Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention